ArticleJAMA network open2023

US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019.

Meera M Dhodapkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.